Literature DB >> 17149610

CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder.

Wilhelm Nimphius1, Roland Moll, Peter Olbert, Annette Ramaswamy, Peter J Barth.   

Abstract

CD34+ fibrocytes are constitutive elements of the connective tissue where they play a role in matrix synthesis and tumor-associated stromal remodeling. Secreted protein, acidic, and rich in cysteine (SPARC) is a pivotal mediator of stromal remodeling precipitated by invasive carcinomas. The present study was undertaken to investigate CD34+ fibrocytes in the stroma of the tumor-free urinary bladder, chronic cystitis, and urothelial carcinomas together with stromal expression of alpha-smooth muscle actin (alpha-SMA), CD117, and SPARC. In tumor-free urinary bladder and chronic cystitis, CD34+ fibrocytes were found in the deep lamina propria and tunica muscularis, whereas the superficial lamina propria disclosed a CD34-negative and alpha-SMA-positive fibrocyte-like cell. Invasive urothelial carcinomas revealed a complete loss of CD34+ fibrocytes and concomitant appearance of alpha-SMA-reactive myofibroblasts which showed strong expression of SPARC. CD117 expression of tumor-free and tumor-associated stroma revealed no differences. We in this study for the first time describe CD34+ fibrocytes in the urinary bladder and an up-to-now unknown population of alpha-SMA-positive fibrocytes exclusively occurring in the superficial lamina propria. Stromal remodeling associated with invasive carcinomas in the urinary bladder is characterized by a loss of CD34+ fibrocytes paralleled by a gain of alpha-SMA-positive myofibroblasts and increased expression of SPARC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17149610     DOI: 10.1007/s00428-006-0347-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

2.  The distribution pattern of myofibroblasts in the stroma of human bladder carcinoma depends on their invasiveness.

Authors:  N Shimasaki; N Kuroda; E Miyazaki; Y Hayashi; M Toi; M Hiroi; H Enzan; T Shuin
Journal:  Histol Histopathol       Date:  2006-04       Impact factor: 2.303

3.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

Authors:  J Chesney; M Bacher; A Bender; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  CD34 positive stromal cells in gastric adenocarcinomas.

Authors:  H Nakayama; H Enzan; E Miyazaki; N Kuroda; K Naruse; H Kiyoku; M Toi; M Hiroi
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

5.  Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma.

Authors:  H Nakayama; H Enzan; E Miyazaki; N Kuroda; K Naruse; M Hiroi
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

6.  CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions.

Authors:  Peter J Barth; Schokufe Ebrahimsade; Achim Hellinger; Roland Moll; Annette Ramaswamy
Journal:  Virchows Arch       Date:  2002-02       Impact factor: 4.064

7.  The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.

Authors:  Christine A Iacobuzio-Donahue; Pedram Argani; Paula M Hempen; Jessa Jones; Scott E Kern
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

8.  CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1.

Authors:  Edgar M Espana; Tetsuya Kawakita; Chia-Yang Liu; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

9.  The cytokine regulation of SPARC production by rabbit corneal epithelial cells and fibroblasts in vitro.

Authors:  Kosuke Abe; Tsuyoshi Hibino; Hiroshi Mishima; Yoshikazu Shimomura
Journal:  Cornea       Date:  2004-03       Impact factor: 2.651

10.  TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors.

Authors:  M J Reed; R B Vernon; I B Abrass; E H Sage
Journal:  J Cell Physiol       Date:  1994-01       Impact factor: 6.384

View more
  15 in total

1.  Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells.

Authors:  Julia Schulte; Michaela Weidig; Philipp Balzer; Petra Richter; Marcus Franz; Kerstin Junker; Mieczyslaw Gajda; Karlheinz Friedrich; Heiko Wunderlich; Arne Östman; Iver Petersen; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2012-07-22       Impact factor: 4.304

Review 2.  Fibrocytes in the Tumor Microenvironment.

Authors:  David Roife; Jason B Fleming; Richard H Gomer
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Bone marrow progenitor cells do not contribute to liver fibrogenic cells.

Authors:  Bruno Diaz Paredes; Lanuza Alaby Pinheiro Faccioli; Luiz Fernando Quintanilha; Karina Dutra Asensi; Camila Zaverucha do Valle; Paulo César Canary; Christina Maeda Takiya; Antonio Carlos Campos de Carvalho; Regina Coeli Dos Santos Goldenberg
Journal:  World J Hepatol       Date:  2012-10-27

4.  Fibrocytes: emerging effector cells in chronic inflammation.

Authors:  Ronald A Reilkoff; Richard Bucala; Erica L Herzog
Journal:  Nat Rev Immunol       Date:  2011-05-20       Impact factor: 53.106

5.  Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Authors:  Neveen Said; Henry F Frierson; Marta Sanchez-Carbayo; Rolf A Brekken; Dan Theodorescu
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

6.  CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin.

Authors:  Cordula Wessel; Christina C Westhoff; Katharina Nowak; Ingrid Moll; Peter J Barth
Journal:  Virchows Arch       Date:  2008-09-24       Impact factor: 4.064

Review 7.  The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

Review 8.  Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Int J Biochem Cell Biol       Date:  2009-10-20       Impact factor: 5.085

Review 9.  Intestinal fibrosis in IBD--a dynamic, multifactorial process.

Authors:  Florian Rieder; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.